Literature DB >> 2682864

Immediate effect of various treatments on lung function in infants with cystic fibrosis.

C Maayan1, E Bar-Yishay, T Yaacobi, Y Marcus, D Katznelson, Y Yahav, S Godfrey.   

Abstract

The immediate effect of four different modes of treatment was assessed by lung function tests on 19 infants with cystic fibrosis (CF) during the first year of life. The regimens were applied in a randomized fashion and consisted of aerosol inhalation of salbutamol (n = 8; SAL), aerosol inhalation of N-acetyl cysteine (n = 5; AC), chest physiotherapy (n = 6; CPT), and combined treatment with aerosol inhalation of SAL and AC followed by CPT (n = 6; COMB). Pulmonary function was measured before and shortly after therapy with each mode of treatment. Thoracic gas volume (Vtg) and specific airway conductance (SGaw) were measured by an infant whole body plethysmograph, and forced expiratory flow at resting lung volume (VmaxFRC) was determined with a thoraco-abdominal squeeze jacket. There was no correlation between baseline lung function and changes in any parameter due to treatment. Overall group comparison showed that the combined therapy resulted in a significant improvement in lung function when compared to any of the three treatments applied separately. There was no significant change in lung volumes in any individual group, but SGaw and VmaxFRC showed a small but significant improvement following the COMB treatment when compared with AC or CPT.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2682864     DOI: 10.1159/000195725

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  12 in total

Review 1.  Physiotherapy in cystic fibrosis.

Authors:  S A Prasad; E L Tannenbaum; C Mikelsons
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

2.  N-acetylcysteine inhibits germination of conidia and growth of Aspergillus spp. and Fusarium spp.

Authors:  A J De Lucca; T J Walsh; D J Daigle
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

3.  N-Acetyl-l-cysteine effects on multi-species oral biofilm formation and bacterial ecology.

Authors:  K Rasmussen; J Nikrad; C Reilly; Y Li; R S Jones
Journal:  Lett Appl Microbiol       Date:  2015-12-09       Impact factor: 2.858

Review 4.  Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.

Authors:  Julian Tam; Edward F Nash; Felix Ratjen; Elizabeth Tullis; Anne Stephenson
Journal:  Cochrane Database Syst Rev       Date:  2013-07-12

Review 5.  Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis.

Authors:  E Main; A Prasad; C Schans
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

Review 6.  Monitoring early inflammation in CF. Infant pulmonary function testing.

Authors:  Jack K Sharp
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

Review 7.  Endpoints for clinical trials in young children with cystic fibrosis.

Authors:  Stephanie D Davis; Alan S Brody; Mary J Emond; Lyndia C Brumback; Margaret Rosenfeld
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

8.  N-Acetyl-L-cysteine and its derivatives activate a Cl- conductance in epithelial cells.

Authors:  M Köttgen; A E Busch; M J Hug; R Greger; K Kunzelmann
Journal:  Pflugers Arch       Date:  1996-02       Impact factor: 3.657

9.  Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.

Authors:  Drucy Borowitz; Karen A Robinson; Margaret Rosenfeld; Stephanie D Davis; Kathryn A Sabadosa; Stephanie L Spear; Suzanne H Michel; Richard B Parad; Terry B White; Philip M Farrell; Bruce C Marshall; Frank J Accurso
Journal:  J Pediatr       Date:  2009-12       Impact factor: 4.406

Review 10.  Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis.

Authors:  Louise Warnock; Alison Gates
Journal:  Cochrane Database Syst Rev       Date:  2015-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.